Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Comment by Stockcoach1on May 03, 2016 11:47am
129 Views
Post# 24837037

RE:RE:RE:McCrum Called it a "Sinful Business Strategy"

RE:RE:RE:McCrum Called it a "Sinful Business Strategy"
WillyWally wrote: It doesn't matter who did. When you buy a company, you are liable for its practices. I'm actually long the stock but arguing that prices were raised before Concordia took ownership has no merit. Just let the shorts pound the stock for a bit and enjoy the cheap shares.

Pj1958 wrote: I didnt didn't watch the interview , but did BNN ask him who actually
raised the price of the eye drops?





Lattice wrote: Well, at least he didn't call it a sewer.

Here is Dan's chat with BNN:  www.bnn.ca/Video/player.aspx?vid=861359

 




Well Willy, it actually has merit when you falsely state that Concordia raised the prices 14 fold when it didn't. It has merit when you falsely state that Concordia's 350% growth year over year is due to price increases and gouging. It has merit when you use these false statement and slander Concordia by comparing them to Martin Shrikelli. 
 FT reporter McCrum crossed the line and should be scrambling to retract, if he realizes the consequences of slander and false reporting.
<< Previous
Bullboard Posts
Next >>